Table 1 Demographic and clinical characteristics
Factors | PICC-related venous thrombosis | No PICC-related venous thrombosis |
|---|---|---|
n = 482 | n = 1,745 | |
Age > 65 years old | 133 (27.59%) | 299 (17.13%) |
Male | 264 (54.77%) | 747 (42.81%) |
BMI ≥ 25 | 98 (20.33%) | 397 (22.75%) |
White blood cell count > 9.5 × 109 /L | 96 (19.92%) | 221 (12.66%) |
Platelet count > 350 × 109 /L | 37 (7.68%) | 130 (7.45%) |
Hemoglobin concentration < 130Â g/L | 340 (70.54%) | 1115 (63.90%) |
D-dimer concentration > 0.5Â mg/L | 105 (21.78%) | 278 (15.93%) |
APTT < 25Â s | 95 (19.71%) | 141 (8.08%) |
Multiple Myeloma | 8 (1.66%) | 28 (1.60%) |
Lung Cancer | 130 (26.97%) | 266 (15.24%) |
Gastrointestinal Tumor | 49 (10.16%) | 86 (4.93%) |
Hematologic neoplasms | 80 (16.60%) | 277 (15.87%) |
Metastasis | 151 (31.33%) | 479 (27.45%) |
Diabetes | 49 (10.17%) | 130 (7.45%) |
Hyperlipidemia | 19 (3.94%) | 69 (3.95%) |
Any infection | 220 (45.64%) | 133 (7.62%) |
Smoking | 98 (20.33%) | 174 (9.97%) |
Cisplatin | 122 (25.31%) | 183 (10.49%) |
Carboplatin | 120 (24.90%) | 307 (17.59%) |
Vincristine | 41 (8.51%) | 67 (3.84%) |
Epirubicin | 109 (22.61%) | 359 (20.57%) |
Paclitaxel | 154 (31.95%) | 388 (22.23%) |
Docetaxel | 56 (11.62%) | 198 (11.35%) |
History of central venous catheter | 58 (12.03%) | 177 (10.14%) |
5 Fr catheter | 51 (10.58%) | 72 (4.13%) |
Polyurethane PICC | 319 (66.18%) | 702 (40.23%) |
Open-ended catheter | 66 (13.69%) | 175 (10.03%) |
Right-side catheter | 189 (39.21%) | 685 (39.26%) |
Non-basilic vein catheter | 42 (8.71%) | 147 (8.42%) |
Catheter displacement | 17 (3.53%) | 36 (2.06%) |
Keeping time of the catheter (days) | 118.56 ± 68.258 | 130.60 ± 57.736 |